This comprehensive report analyzes the global osteoarthritis cell therapy market, which is projected to experience significant growth through 2032. Focusing on innovative treatments such as chondrocytes and mesenchymal stem cells, the study examines market dynamics across various applications and geographic regions, including the Americas, APAC, and Europe. By evaluating key players, technological advancements, and competitive strategies, the report provides detailed insights into market segmentation, emerging opportunities, and the future trajectory of this rapidly accelerating industry.

Market Overview

Global Market Projections

The global Osteoarthritis Cell Therapy market size is predicted to grow from US$ 414 million in 2025 to US$ 2724 million in 2032; it is expected to grow at a CAGR of 31.5% from 2026 to 2032.

Regional Market Projections

• United States: The market for Osteoarthritis Cell Therapy is estimated to experience growth from 2025 through 2032.
• China: The market for Osteoarthritis Cell Therapy is estimated to experience growth from 2025 through 2032.
• Europe: The market for Osteoarthritis Cell Therapy is estimated to experience growth from 2025 through 2032.

Product Description

Osteoarthritis Cell Therapy is an innovative treatment approach for osteoarthritis. It primarily involves the use of specific cells such as chondrocytes and mesenchymal stem cells. These cells are usually obtained from the patient's own joint cartilage, bone marrow, or adipose tissue, and then cultured, expanded, or induced to differentiate in vitro. Subsequently, they are implanted into the joint through intra-articular injection or tissue-engineered transplantation.

Report Scope and Methodology

Research Objectives

LPI (LP Information)' newest research report, the “Osteoarthritis Cell Therapy Industry Forecast” looks at past sales and reviews total world Osteoarthritis Cell Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Cell Therapy sales for 2026 through 2032. With Osteoarthritis Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Osteoarthritis Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Osteoarthritis Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Cell Therapy market.

Analytical Approach

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Cell Therapy market by product type, application, key players and key regions and countries.

Market Segmentation

By Type

• Chondrocytes
• Mesenchymal Stem Cells
• Others

By Application

• Primary Osteoarthritis
• Secondary Osteoarthritis

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Dynamics

Global key Osteoarthritis Cell Therapy players cover Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, etc. In terms of revenue, the global two largest companies occupied a significant share in 2025.

Profiled Companies

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and its market penetration:

• Vericel
• Medi-post
• Zimmer Biomet
• Japan Tissue Engineering
• Orthocell
• Cambium Bio
• CO.DON GmbH
• Regrow Biosciences
• Theracell Advanced Biotechnology
• Nature Cell
• Stempeutics
• Xintela AB
• Cells for Cells
• CellTex Therapeutics
• UCI Health
• Magellan
• AbelZeta Pharma

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Osteoarthritis Cell Therapy Market Size (2021-2032)

    • 2.1.2 Osteoarthritis Cell Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Osteoarthritis Cell Therapy by Country/Region (2021, 2025 & 2032)

  • 2.2 Osteoarthritis Cell Therapy Segment by Type

    • 2.2.1 Chondrocytes

    • 2.2.2 Mesenchymal Stem Cells

    • 2.2.3 Others

    • 2.2.4 Osteoarthritis Cell Therapy Market Size by Type

      • 2.2.4.1 Osteoarthritis Cell Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Osteoarthritis Cell Therapy Market Size Market Share by Type (2021-2026)

  • 2.3 Osteoarthritis Cell Therapy Segment by Application

    • 2.3.1 Primary Osteoarthritis

    • 2.3.2 Secondary Osteoarthritis

    • 2.3.3 Osteoarthritis Cell Therapy Market Size by Application

      • 2.3.3.1 Osteoarthritis Cell Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.3.2 Global Osteoarthritis Cell Therapy Market Size Market Share by Application (2021-2026)

• 3 Osteoarthritis Cell Therapy Market Size by Player

  • 3.1 Osteoarthritis Cell Therapy Market Size Market Share by Player

    • 3.1.1 Global Osteoarthritis Cell Therapy Revenue by Player (2021-2026)

    • 3.1.2 Global Osteoarthritis Cell Therapy Revenue Market Share by Player (2021-2026)

  • 3.2 Global Osteoarthritis Cell Therapy Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Osteoarthritis Cell Therapy by Region

  • 4.1 Osteoarthritis Cell Therapy Market Size by Region (2021-2026)

  • 4.2 Global Osteoarthritis Cell Therapy Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Osteoarthritis Cell Therapy Market Size Growth (2021-2026)

  • 4.4 APAC Osteoarthritis Cell Therapy Market Size Growth (2021-2026)

  • 4.5 Europe Osteoarthritis Cell Therapy Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Osteoarthritis Cell Therapy Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Osteoarthritis Cell Therapy Market Size by Country (2021-2026)

  • 5.2 Americas Osteoarthritis Cell Therapy Market Size by Type (2021-2026)

  • 5.3 Americas Osteoarthritis Cell Therapy Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Osteoarthritis Cell Therapy Market Size by Region (2021-2026)

  • 6.2 APAC Osteoarthritis Cell Therapy Market Size by Type (2021-2026)

  • 6.3 APAC Osteoarthritis Cell Therapy Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Osteoarthritis Cell Therapy Market Size by Country (2021-2026)

  • 7.2 Europe Osteoarthritis Cell Therapy Market Size by Type (2021-2026)

  • 7.3 Europe Osteoarthritis Cell Therapy Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Osteoarthritis Cell Therapy by Region (2021-2026)

  • 8.2 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Osteoarthritis Cell Therapy Market Forecast

  • 10.1 Global Osteoarthritis Cell Therapy Forecast by Region (2027-2032)

    • 10.1.1 Global Osteoarthritis Cell Therapy Forecast by Region (2027-2032)

    • 10.1.2 Americas Osteoarthritis Cell Therapy Forecast

    • 10.1.3 APAC Osteoarthritis Cell Therapy Forecast

    • 10.1.4 Europe Osteoarthritis Cell Therapy Forecast

    • 10.1.5 Middle East & Africa Osteoarthritis Cell Therapy Forecast

  • 10.2 Americas Osteoarthritis Cell Therapy Forecast by Country (2027-2032)

    • 10.2.1 United States Market Osteoarthritis Cell Therapy Forecast

    • 10.2.2 Canada Market Osteoarthritis Cell Therapy Forecast

    • 10.2.3 Mexico Market Osteoarthritis Cell Therapy Forecast

    • 10.2.4 Brazil Market Osteoarthritis Cell Therapy Forecast

  • 10.3 APAC Osteoarthritis Cell Therapy Forecast by Region (2027-2032)

    • 10.3.1 China Osteoarthritis Cell Therapy Market Forecast

    • 10.3.2 Japan Market Osteoarthritis Cell Therapy Forecast

    • 10.3.3 Korea Market Osteoarthritis Cell Therapy Forecast

    • 10.3.4 Southeast Asia Market Osteoarthritis Cell Therapy Forecast

    • 10.3.5 India Market Osteoarthritis Cell Therapy Forecast

    • 10.3.6 Australia Market Osteoarthritis Cell Therapy Forecast

  • 10.4 Europe Osteoarthritis Cell Therapy Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Osteoarthritis Cell Therapy Forecast

    • 10.4.2 France Market Osteoarthritis Cell Therapy Forecast

    • 10.4.3 UK Market Osteoarthritis Cell Therapy Forecast

    • 10.4.4 Italy Market Osteoarthritis Cell Therapy Forecast

    • 10.4.5 Russia Market Osteoarthritis Cell Therapy Forecast

  • 10.5 Middle East & Africa Osteoarthritis Cell Therapy Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Osteoarthritis Cell Therapy Forecast

    • 10.5.2 South Africa Market Osteoarthritis Cell Therapy Forecast

    • 10.5.3 Israel Market Osteoarthritis Cell Therapy Forecast

    • 10.5.4 Turkey Market Osteoarthritis Cell Therapy Forecast

  • 10.6 Global Osteoarthritis Cell Therapy Forecast by Type (2027-2032)

  • 10.7 Global Osteoarthritis Cell Therapy Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Osteoarthritis Cell Therapy Forecast

• 11 Key Players Analysis

  • 11.1 Vericel

    • 11.1.1 Vericel Company Information

    • 11.1.2 Vericel Osteoarthritis Cell Therapy Product Offered

    • 11.1.3 Vericel Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Vericel Main Business Overview

    • 11.1.5 Vericel Latest Developments

  • 11.2 Medi-post

    • 11.2.1 Medi-post Company Information

    • 11.2.2 Medi-post Osteoarthritis Cell Therapy Product Offered

    • 11.2.3 Medi-post Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Medi-post Main Business Overview

    • 11.2.5 Medi-post Latest Developments

  • 11.3 Zimmer Biomet

    • 11.3.1 Zimmer Biomet Company Information

    • 11.3.2 Zimmer Biomet Osteoarthritis Cell Therapy Product Offered

    • 11.3.3 Zimmer Biomet Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Zimmer Biomet Main Business Overview

    • 11.3.5 Zimmer Biomet Latest Developments

  • 11.4 Japan Tissue Engineering

    • 11.4.1 Japan Tissue Engineering Company Information

    • 11.4.2 Japan Tissue Engineering Osteoarthritis Cell Therapy Product Offered

    • 11.4.3 Japan Tissue Engineering Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Japan Tissue Engineering Main Business Overview

    • 11.4.5 Japan Tissue Engineering Latest Developments

  • 11.5 Orthocell

    • 11.5.1 Orthocell Company Information

    • 11.5.2 Orthocell Osteoarthritis Cell Therapy Product Offered

    • 11.5.3 Orthocell Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Orthocell Main Business Overview

    • 11.5.5 Orthocell Latest Developments

  • 11.6 Cambium Bio

    • 11.6.1 Cambium Bio Company Information

    • 11.6.2 Cambium Bio Osteoarthritis Cell Therapy Product Offered

    • 11.6.3 Cambium Bio Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Cambium Bio Main Business Overview

    • 11.6.5 Cambium Bio Latest Developments

  • 11.7 CO.DON GmbH

    • 11.7.1 CO.DON GmbH Company Information

    • 11.7.2 CO.DON GmbH Osteoarthritis Cell Therapy Product Offered

    • 11.7.3 CO.DON GmbH Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 CO.DON GmbH Main Business Overview

    • 11.7.5 CO.DON GmbH Latest Developments

  • 11.8 Regrow Biosciences

    • 11.8.1 Regrow Biosciences Company Information

    • 11.8.2 Regrow Biosciences Osteoarthritis Cell Therapy Product Offered

    • 11.8.3 Regrow Biosciences Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Regrow Biosciences Main Business Overview

    • 11.8.5 Regrow Biosciences Latest Developments

  • 11.9 Theracell Advanced Biotechnology

    • 11.9.1 Theracell Advanced Biotechnology Company Information

    • 11.9.2 Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Product Offered

    • 11.9.3 Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Theracell Advanced Biotechnology Main Business Overview

    • 11.9.5 Theracell Advanced Biotechnology Latest Developments

  • 11.10 Nature Cell

    • 11.10.1 Nature Cell Company Information

    • 11.10.2 Nature Cell Osteoarthritis Cell Therapy Product Offered

    • 11.10.3 Nature Cell Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Nature Cell Main Business Overview

    • 11.10.5 Nature Cell Latest Developments

  • 11.11 Stempeutics

    • 11.11.1 Stempeutics Company Information

    • 11.11.2 Stempeutics Osteoarthritis Cell Therapy Product Offered

    • 11.11.3 Stempeutics Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Stempeutics Main Business Overview

    • 11.11.5 Stempeutics Latest Developments

  • 11.12 Xintela AB

    • 11.12.1 Xintela AB Company Information

    • 11.12.2 Xintela AB Osteoarthritis Cell Therapy Product Offered

    • 11.12.3 Xintela AB Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Xintela AB Main Business Overview

    • 11.12.5 Xintela AB Latest Developments

  • 11.13 Cells for Cells

    • 11.13.1 Cells for Cells Company Information

    • 11.13.2 Cells for Cells Osteoarthritis Cell Therapy Product Offered

    • 11.13.3 Cells for Cells Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Cells for Cells Main Business Overview

    • 11.13.5 Cells for Cells Latest Developments

  • 11.14 CellTex Therapeutics

    • 11.14.1 CellTex Therapeutics Company Information

    • 11.14.2 CellTex Therapeutics Osteoarthritis Cell Therapy Product Offered

    • 11.14.3 CellTex Therapeutics Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 CellTex Therapeutics Main Business Overview

    • 11.14.5 CellTex Therapeutics Latest Developments

  • 11.15 UCI Health

    • 11.15.1 UCI Health Company Information

    • 11.15.2 UCI Health Osteoarthritis Cell Therapy Product Offered

    • 11.15.3 UCI Health Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 UCI Health Main Business Overview

    • 11.15.5 UCI Health Latest Developments

  • 11.16 Magellan

    • 11.16.1 Magellan Company Information

    • 11.16.2 Magellan Osteoarthritis Cell Therapy Product Offered

    • 11.16.3 Magellan Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Magellan Main Business Overview

    • 11.16.5 Magellan Latest Developments

  • 11.17 AbelZeta Pharma

    • 11.17.1 AbelZeta Pharma Company Information

    • 11.17.2 AbelZeta Pharma Osteoarthritis Cell Therapy Product Offered

    • 11.17.3 AbelZeta Pharma Osteoarthritis Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 AbelZeta Pharma Main Business Overview

    • 11.17.5 AbelZeta Pharma Latest Developments

• 12 Research Findings and Conclusion